MSP submits £60m Citylabs plans
Bruntwood’s Manchester Science Partnerships has submitted plans for a £60m expansion of its science innovation campus Citylabs.
The development, a joint venture between MSP and the Central Manchester University Hospitals NHS Foundation Trust, will provide 220,000 sq ft of office, laboratory and collaboration space across Citylabs 2.0 and 3.0. The developments are targeted at health and medical technology companies.
Bruntwood’s Manchester Science Partnerships has submitted plans for a £60m expansion of its science innovation campus Citylabs.
The development, a joint venture between MSP and the Central Manchester University Hospitals NHS Foundation Trust, will provide 220,000 sq ft of office, laboratory and collaboration space across Citylabs 2.0 and 3.0. The developments are targeted at health and medical technology companies.
From July: Manchester cooks up £60m for Citylabs
Phase 1, the £25m Citylabs 2.0 development, will comprise 92,000 sq ft of lab and office space. Subject to planning permission being granted, construction will begin in autumn 2017, with completion expected in late 2018.
Phase 2, the £35m Citylabs 3.0, will span 128,000 sq ft and integrate the development of new buildings with the old Saint Mary’s Hospital, an existing listed Victorian building. Construction is planned to start in summer 2018 and is due to be completed in 2020.
Chris Roberts, development director at Bruntwood, which has submitted the application on behalf of MSP, said: “The planned expansion of Citylabs is a great vote of confidence in Manchester and alongside the existing major developments on the city’s innovation district – such as Circle Square and the Alliance Manchester Business School – will reinforce its credentials as a world class location for science and technology businesses.”
• To send feedback, e-mail louisa.clarence-smith@estatesgazette.com or tweet @LouisaClarence or @estatesgazette
